PT  - JOURNAL ARTICLE
AU  - Nhacolo, Ariel Q.
AU  - Madewell, Zachary J.
AU  - Muir, Jonathan A.
AU  - Sacoor, Charfudin N.
AU  - Xerinda, Elisio G.
AU  - Matsena, Teodimiro
AU  - Bassat, Quique
AU  - Whitney, Cynthia G.
AU  - Mandomando, Inácio M.
AU  - Cunningham, Solveig A.
TI  - Knowledge of COVID-19 Symptoms, Transmission, and Prevention: Evidence from Health and Demographic Surveillance in Southern Mozambique
AID  - 10.1101/2023.03.31.23288026
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.03.31.23288026
4099  - http://medrxiv.org/content/early/2023/06/30/2023.03.31.23288026.short
4100  - http://medrxiv.org/content/early/2023/06/30/2023.03.31.23288026.full
AB  - Over 230,000 COVID-19 cases and over 2,200 deaths have been reported in Mozambique though May 2023. Understanding community members’ knowledge of SARS-CoV-2 transmission and prevention is essential for directing public health interventions to reduce disease spread and improve vaccination coverage. Here, we describe knowledge of COVID-19 transmission, prevention, and symptoms among community residents in Mozambique. We conducted a cross-sectional survey among 33,087 households in a Health and Demographic Surveillance System in Manhiça, Mozambique. Participants were recruited at the tail end of the Delta variant wave in September 2021 to the peak of Omicron cases in January 2022. Principal components analysis was used to create scores representing knowledge of COVID-19 symptoms, transmission, and prevention. Multiple imputation and quasi-Poisson regression were used to examine associations between demographic characteristics and sources of COVID-19 information, and knowledge of COVID-19 symptoms, transmission, and prevention. We examined whether sources of COVID-19 information mediated the relationship between educational attainment and knowledge of symptoms, transmission, and prevention. Across this rural community, 98.2%, 97.0%, and 85.1% of respondents reported knowing how COVID-19 could be prevented, that SARS-CoV-2 can cause disease, and how SARS-CoV-2 is transmitted, respectively. Most cited symptoms were cough (51.2%), headaches (44.9%), and fever (44.5%); transmission mechanisms were droplets (50.5%) or aerosol (<5 µm diameter) (46.9%) from an infected person; and prevention measures were handwashing (91.9%) and mask-wearing (91.8%). Characteristics associated with greater knowledge of symptoms, transmission, and prevention included having at least primary education, older age, employment, higher wealth, and Christian religion. Respondents who had had COVID-19 symptoms were also more likely to have knowledge of symptoms, transmission, and prevention. Gathering information from TV, WhatsApp, radio, and hospital mediated the relationship between educational attainment and knowledge scores. These findings support the need for outreach and for community-engaged messaging to promote prevention measures, particularly among people with low education.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported, in whole or in part, by grant OPP1126780 from the Bill & Melinda Gates Foundation to Dr. Cynthia Whitney. Under the grant conditions of the Foundation, a Creative Commons Attribution 4.0 Generic License has already been assigned to the Author Accepted Manuscript version that might arise from this submission. CISM is supported by the Government of Mozambique and the Spanish Agency for International Development (AECID).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The HDSS data collection has ethical approval from the Institutional Ethics Review Board for Health (CIBS) and Internal Scientific Committee (CCI) at CISM, and the National Bioethics Committee for Health (CNBS-Mozambique). This study used part of the existing HDSS data, for which all the heads of households and household members in Manhica district have voluntarily agreed and signed a written detailed informed consent for providing their demographic and socio-economic data, including that of their households and their young dependents (children under the age of 18 years), in the context of HDSS. In relation to new data, the study team obtained approval from CISM's CCI and CIBS to collect the data based on voice-recorded informed oral consent to minimize the risk of COVID-19 transmission when handling paper-based informed and signed consents between interviewers and interviewees. Data collection was mainly over the phone to minimize contacts due to COVID-19. Even during household visits (which were done for participants unreachable by phone), informed consent was oral and voice-recorded to minimize the risk of COVID-19. Written informed consent was obtained from the parent or guardian of each participant under 18 years of age. All communications with study participants were done with the language of each participant's preference. Where the preferred language was not Portuguese, the fieldworkers translated the questionnaires in situs as in other studies that the HDSS and social science team has conducted. Where the fieldworker could not speak the participant's preferred language, a translator was sought in the household, or a suitable fieldworker conducted the communication at another time. Data collection was done between September 2021 and January 2022. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors